Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADAGRASIB vs ADALIMUMAB-AATY: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADAGRASIB vs ADALIMUMAB-AATY: Safety Overview

Metric ADAGRASIB ADALIMUMAB-AATY
Total FAERS Reports 899 1,679
Deaths Reported 315 147
Death Rate 35.0% 8.8%
Hospitalizations 350 384
Average Patient Age 68.3 yrs 51.8 yrs
% Female Patients 56.4% 72.2%
FDA Approval Date Dec 12, 2022 N/A
Manufacturer Mirati Therapeutics, Inc CELLTRION USA, Inc.
Route ORAL N/A
Marketing Status Prescription Prescription